Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Carboplatin 11 atezolizumab 10 Etoposide 9 durvalumab 6 Topotecan 6 PM 01183 6 Specimen Handling 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Irinotecan 2 Injections 2 Drug Therapy 2 Cisplatin 2 Biopsy 2 AMG 757 2 tremelimumab 1 trastuzumab deruxtecan 1 toripalimab 1 olaparib 1 lenvatinib 1 fludarabine 1 enzalutamide 1 cabozantinib 1 berzosertib 1 avelumab 1 arginine decarboxylase 1 amrubicin 1 Vaccines 1 Taxes 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × MLN 8237 × 30 days × Clear all

NCT06095505 2026-06-05

ALISCA-Lung1

Puma Biotechnology, Inc.

Phase 2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡